1060. Pritelivir in Immunocompromised Patients with Mucocutaneous Acyclovir-Resistant Herpes Simplex Virus-Infections – First Case Series

BACKGROUND: HSV recurrences are usually managed effectively with existing antiviral drugs (nucleoside analogs such as acyclovir). However, in immunocompromised patients (e.g., malignancy, HIV, transplant), if lesions persist or recur while receiving antiviral treatment, acyclovir resistance should b...

Descripción completa

Detalles Bibliográficos
Autores principales: Albrecht, Kim WorkowskiJoerg, Avery, Robin K, Chandrasekar, Pranatharthi, Chemaly, Roy F, Issa, Nicolas C, Kotton, Camille, Kumar, Princy N, Mayur, Ramesh, Ramgopal, Moti, Schiffer, Joshua, Wald, Anna, Ison, Michael G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644964/
http://dx.doi.org/10.1093/ofid/ofab466.1254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644964/
http://dx.doi.org/10.1093/ofid/ofab466.1254

Ejemplares similares